[1]
“EXPERIENCE IN OPTIMIZING PHARMACOTHERAPY BASED ON CLINICAL OBSERVATIONS OF PATIENTS AFTER MYOCARDIAL INFARCTION WITH CHRONIC HEART FAILURE AND REDUCED AND MID-RANGE LEFT VENTRICULAR EJECTION FRACTION”, ijms, vol. 6, no. 02, pp. 181–184, Feb. 2026, doi: 10.55640/.